Maximize your research potentialin partnership with RD-Biotech
RD-Biotech is a biotechnology company that offers tailor-made solutions in Molecular Biology, Immunology and Cellular Engineering, as part of Research & Development, pre-clinical or clinical studies. Since its creation in 2002, RD-Biotech provides technical skills and scientific know-how for a personalized, responsive and quality service, and with complete confidentiality.
Our services
RD-Biotech is at your disposal to meet your needs and accelerate your research.
From a feasibility study to the development and production of your biological reagents: DNA, antibodies, recombinant proteins, cells…
Our products
RD-Biotech offers you quality and ready-to-use products, available in catalogue and bulk format…
Ready-to-use cells
RD-Biotech produces and supplies MRC-5, VERO, HEP2 cells, supply of cultured cells or frozen cells, for applications in virology
FastELISA kits
Range of one-step ELISA kits, murine, human, rat Ig quantification, isotyping, protein A, bovine Ig, HCP contaminant detection, and Fc Fusion assay.
Rabies antibodies
Production, monoclonal antibodies anti rabies, D1-25 and 1112-1 clones, quantification by ELISA of rabies virus.
+20
years of experience and expertise
+500
antibodies produced per year
+1500
plasmids produced per year
+98%
response within 24h
"We have the ambition to become a partner of choicein the realization of your projects by saving you timeand allowing you to reduce your operating costs"
— Philippe Dulieu, President of RD-Biotech
Actuality
RD-Biotech, a complete platform from DNA to antibody
For your antibody development projects, for applications in immunotherapy, diagnostics, research: contact our team of experts in molecular biology and antibody engineering.
Contact us for more information!
RD-Biotech is here to help you in your projects related to Covid-19!
Development / Production of monoclonal or recombinant antibodies - Expression vector construction - Antigen expression - DNA plasmid production...
Contact us for more information!
Our sister company, Diaclone, is now part of the Medix Biochemica group
Biotech Investissement (www.mabexperts.com) separates from its subsidiary Diaclone by selling it to Medix Biochemica.
The arrival of Diaclone in the Medix group will allow it to access new international markets, and therefore to continue its growth in the In Vitro Diagnostics (IVD) market.
Our group will now focus on the development of biomanufacturing services for plasmid DNAs, antibodies and recombinant proteins with in particular the upcoming construction of a new DNA production unit, GMP grade (BPF) at RD-BIOTECH.
More information: Biotech Investissement communication
Contact us: info@rd-biotech.com